Quick Search:

uzh logo
Browse by:

Zurich Open Repository and Archive

Maintenance: Tuesday, July the 26th 2016, 07:00-10:00

ZORA's new graphical user interface will be relaunched (For further infos watch out slideshow ZORA: Neues Look & Feel). There will be short interrupts on ZORA Service between 07:00am and 10:00 am. Please be patient.

Enseleit, F; Lüscher, T F; Ruschitzka, F (2008). Darusentan: a new perspective for treatment of resistant hypertension? Expert Opinion on Investigational Drugs, 17(8):1255-1263.

Full text not available from this repository.

View at publisher


Despite multi-drug therapy, hypertension remains uncontrolled in a significant amount of patients, especially those with multiple cardiovascular risk factors. Endothelin-1 is a long lasting and very potent vasoconstrictor and plays a key role in cardiovascular hemostasis. Endothelin mediates its biological activity in humans through the endothelin A and B receptors. The selective endothelin--A receptor antagonist darusentan may be a new treatment option in patients with resistant hypertension. The objectives were that the clinical experience and the evidence for therapy with darusentan in resistant systemic hypertension were reviewed. The methods by the authors were that the leading journals which publish basic science and clinical research in the area of cardiovascular diseases and PubMed were scanned. In conclusion, early clinical results from Phase II studies suggest that darusentan may find a place in the treatment of resistant hypertension.


6 citations in Web of Science®
9 citations in Scopus®
Google Scholar™


Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiology
Dewey Decimal Classification:610 Medicine & health
Date:August 2008
Deposited On:15 Dec 2008 10:25
Last Modified:05 Apr 2016 12:42
Publisher:Informa Healthcare
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:10.1517/13543784.17.8.1255
PubMed ID:18616421

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page